超声联合微泡可增加小鼠原位胰腺肿瘤对铂的摄取
研究探讨超声联合微泡能否提高FOLFIRINOX在原发性胰腺导管腺癌(PDAC)小鼠模型中的摄取及治疗反应。结果显示超声处理可显著增加肿瘤中铂(奥沙利铂活性成分)的摄取,多次注射FOLFIRINOX亦增加铂含量,但增强的蓄积并未改善治疗反应。结论提示超声联合微泡在临床实践中具有潜力,但需进一步研究克服基质屏障。
要点
- 超声联合微泡可显著增加原位PDAC肿瘤对铂的摄取。
- 多次注射FOLFIRINOX可增加肿瘤内铂含量。
- 铂摄取增加未转化为治疗反应的改善。
局限性
- 研究为小鼠模型,结果外推到临床需谨慎。
- 未明确样本量、中心数及具体超声参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Currently available cytotoxic treatments have limited effect on pancreatic ductal adenocarcinoma (PDAC) because desmoplastic stroma limits drug delivery. Efforts have been made to overcome these barriers by drug targeting the tumor microenvironment. Results so far are promising, but without clinical impact. Our aim was to investigate whether ultrasound and microbubbles could improve the uptake and therapeutic response of conventional chemotherapy.
METHODS: Orthotopic pancreatic tumors growing in mice were treated with commercially available FOLFIRINOX (fluorouracil, irinotecan, oxaliplatin and calcium folinate) and SonoVue microbubbles combined with focused ultrasound. Tumor uptake of platinum (Pt) was measured by inductively coupled plasma mass spectroscopy (ICP-MS), and tumor volumes were measured by ultrasound imaging.
DISCUSSION: Uptake of Pt, the active ingredient of oxaliplatin, was significantly increased after ultrasound treatment of orthotopic PDAC tumors. Multiple injections with FOLFIRONOX increased the amount of Pt in tumors. However, the enhanced accumulation did not improve therapeutic response. Increased uptake of Pt confirms that ultrasound and microbubbles have potential in clinical practice with existing drugs.
CONCLUSION: The lack of therapeutic response, despite increased uptake in tumor tissue, emphasizes the importance of studying how to overcome stromal barriers.
引用
- Haram, Snipstad, Berg, et al. Ultrasound and Microbubbles Increase the Uptake of Platinum in Murine Orthotopic Pancreatic Tumors. Ultrasound Med Biol. 2023. PMID: 36842903. doi:10.1016/j.ultrasmedbio.2023.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。